Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CJASN
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CJASN
-
#SONAR: Do a New Design and Statistically Significant Results Translate to Reliability? http://bit.ly/CJN08540719@lastwalshHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Consenting for
#Dialysis or its Alternative: Systematic Process is Neededhttp://bit.ly/CJN09510819Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In this first of its kind analysis from India, predominantly socioeconomic factors were associated with quality of life scores in patients with
#CKD http://bit.ly/CJN06510619 Editorial: http://bit.ly/CJN14941219 Patient Perspective: http://bit.ly/CJN14101119 pic.twitter.com/alp4OQgFpQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excellent Outcomes with Challenging Patients: 10 Year Outcomes in the
#NationalKidneyRegistry http://bit.ly/CJN06660619@alvinthomas13 Editorial: Is it time to buy into the National Kidney Registry? http://bit.ly/CJN14581119 pic.twitter.com/2Kp6bHTW0K
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A
#SystemsBiology approach to understanding the kidney leverages recent advances in computational technology and methods to integrate diverse sets of data http://bit.ly/CJN09990819 pic.twitter.com/fRvPTh9kLZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Exploring the association of
#klotho gene with salt sensitivity and hypertension http://bit.ly/CJN08620719 pic.twitter.com/5zo2S7Norw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Single Cell Sequencing and
#Kidney Organoids Generated from Pluripotent Stem Cells http://bit.ly/CJN07470619@HumphreysLabpic.twitter.com/WcNAX4t8IJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Explore the Genetic Architecture of
#KidneyDiseases including rare variants and the future directions for research http://bit.ly/CJN09340819 pic.twitter.com/43gLAOX3nP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Introducing a CJASN collection exploring the
#Genomics of Kidney Disease - focusing on methods for discovery and translation, applied genomics, and how it can provide insights into disease pathophysiology, prevention, and treatment http://bit.ly/CJASNGenomics@kidneyomicsampsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Trends in the Proportions of Women Program Chairs, Moderators, and Speakers at ASN
#KidneyWk 2011—2019 http://bit.ly/CJN08140719@kdjhaveripic.twitter.com/uViYfZ3PxK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sodium Bicarbonate Supplementation and Urinary TGF-β1 in Nonacidotic Diabetic
#KidneyDiseases http://bit.ly/CJN06600619@lukela19pic.twitter.com/MOcXegDIHH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Testing Reproducibility of Deceased
#KidneyDonor Procurement Biopsies http://bit.ly/CJSN09170819@SAHusainMDpic.twitter.com/HIn7ajSfGg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Incidence, Predictors, and Treatment Response of Recurrent
#FSGS in Kidney Transplant Recipients. http://bit.ly/CJN08970719 Editorial by Dr. Richard Lafayette http://bit.ly/CJN14841219@kidneybizpic.twitter.com/VweVhOXnel
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CJASN proslijedio/la je Tweet
#Dialysis patients are at no disadvantage after in-hospital cardiac arrest, according to research led by@virtualpun, MD, of@DCRINews, in@CJASN.@ASNKidney@NIDDKgovhttps://bit.ly/2thMO2bHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CJASN proslijedio/la je Tweet
Podcast by Dr Vicente Torres and Peter Harris on epidemiology of
#ADPKD. Unique study given#Rochester#Epidemiology#Project@MayoClinichttps://twitter.com/CJASN/status/1217495451127230464 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Listen to the newest
@CJASN#podcast on#Epidemiology of Autosomal Dominant#PolycysticKidneyDisease in Olmsted County#ADPKD here: http://bit.ly/CPOD05900519@fouadchebib@marieinmn@mayoclinicpic.twitter.com/19QsUnhDTy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CJASN proslijedio/la je Tweet
@CJASN study challenges our conventional notion of diet in HD patients. There are inevitable confounders- residual renal function being the most important- but, blanket rec of limiting fruits and vegetables to avoid high K may not be appropriate.https://cjasn.asnjournals.org/content/14/2/250 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editor's Pick of
@CJASN 2019: Secular Trends in the Cost of#Immunosuppressants after Solid#OrganTransplantation in the United States http://bit.ly/CJN10590918@mehelmuth@pummy92pic.twitter.com/BedWEx5RE0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CJASN proslijedio/la je Tweet
Really pleased that our paper on ICIs and AKI was so well received by many. Also my first OI manuscript with
@MegSise an amazing mentor, who is so much fun to work with. Thanks to@CJASN for the recognition.@MGHKidneyshttps://twitter.com/CJASN/status/1216767445559660545 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editor's Pick of
@CJASN 2019: The Incidence, Causes, and Risk Factors of#AcuteKidneyInjury in Patients Receiving Immune Checkpoint Inhibitors http://bit.ly/CJN00990119@BetterCallSeeth@megsise @mghnephrologypic.twitter.com/4r19bnM4fu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.